Live News Categoriesequity

PDS Biotechnology Corporation (PDSB) News

Track canonical SquawkNews coverage tagged to PDSB, PDS Biotechnology Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol PDSB Asset equity Sector Markets 90 days 1 Last 0.2551 Updated Aug 11, 2026, 05:49 PM UTC Open live news feed

L PDS Biotechnology Stock Crashes, Strategic Refocus Pivots to Metastatic Colorectal Cancer Program PDS Biotechnology Corporation (NASDAQ: PDSB ) shares have fallen by about 67% on Tuesday as the company announced a strategic refocus on its PDS0301 program for metastatic colorectal cancer. PDS0301 Metastatic Colorectal EQUITY | Aug 11, 2026, 05:49 PM UTC